Studies on Anticoagulation Therapy After Valve Replacement In Cardiac Patients
Not Applicable
- Conditions
- Health Condition 1: I348- Other nonrheumatic mitral valve disorders
- Registration Number
- CTRI/2022/06/043174
- Lead Sponsor
- Juno Angel J
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients of 18 years and above.
2. All patients with single and double mechanical valve replacement will be enrolled.
3. Patients willing to sign their informed consent form will be included in the study.
Exclusion Criteria
1. Any patients with severe heart failure or renal impairments
2. Patients with any malignancy
3. Child bearing potential population will be excluded.
4. Active or latent Hepatitis B or active Hepatitis C
5. Serious co morbidities such as HIV, Tuberculosis etc.
6. Psychiatric illness
7. Patients who deny giving informed Consent
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method